SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-23-001695
Filing Date
2023-06-08
Accepted
2023-06-08 10:40:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3009
  Complete submission text file 0001959173-23-001695.txt   4692
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609 813-553-6680
Pacira BioSciences, Inc. (Subject) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-35060 | Film No.: 231001061
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PACIRA PHARMACEUTICALS, INC. 5 SYLVAN WAY, SUITE 100 PARSIPPANY NJ 07054
Business Address
Kronenfeld Mark A. (Reporting) CIK: 0001578074 (see all company filings)

Type: 144